Blog
Peptide Therapy: Potential, Promise, and Proven Applications in Sports Medicine & Orthopedic Health
Peptides are short amino-acid chains that signal growth, repair, metabolism, and immune responses. In sports medicine and joint preservation, peptide therapy is a tool—not a trend—best used within physician-led programs that prioritize safety, ethics, and measurable outcomes.
FDA‑Approved Peptide Therapies
Only a subset of peptide or peptide‑derived drugs are FDA‑approved. When appropriate, our clinic uses the approved products below with established dosing and monitoring:
| Peptide | Indication | Key Effects |
|---|---|---|
| Teriparatide (PTH 1‑34) | Osteoporosis | Anabolic bone formation; lifetime duration limits apply. |
| Abaloparatide | Osteoporosis | Similar anabolic effects via PTH receptors. |
| GLP‑1 analogs (Semaglutide, Liraglutide, Tirzepatide) | Type 2 diabetes; medical weight management | Improve glycemic control, curb appetite, reduce visceral fat; GI effects are common; thyroid C‑cell tumor warnings apply. |
| Tesamorelin | HIV‑associated lipodystrophy | Reduces visceral adipose tissue; not indicated for general weight loss. |
| Bremelanotide (PT‑141) | HSDD in premenopausal women | On‑demand melanocortin agonist; nausea and BP elevations can occur; dose limits apply. |
Swipe left or scroll horizontally to view the full table.
Clinical note: Approved peptides are prescribed through FDA‑registered pharmacies with counseling on black‑box warnings, contraindications, and follow‑up labs where relevant.
Investigational & Compounded Peptides (Not FDA‑Approved)
Several peptides are under study for inflammation control, tissue repair, metabolic health, cognition, or libido. The compounds below are not FDA‑approved; long‑term safety and efficacy remain uncertain.
| Peptide | Proposed Use | Status & Considerations |
|---|---|---|
| BPC‑157 | Tendon/ligament healing; anti‑inflammatory | Pre‑clinical data only; purity/contamination risks outside regulated channels. |
| TB‑500 (Thymosin‑β4) | Experimental; unapproved for human use in the U.S. | Similar anabolic effects via PTH receptors. |
| CJC‑1295 / Ipamorelin | Investigational; compounding restrictions; potential metabolic/CV effects. | Improve glycemic control, curb appetite, reduce visceral fat; GI effects are common; thyroid C‑cell tumor warnings apply. |
| AOD‑9604 | Insufficient efficacy in rigorous human trials; unapproved. | Reduces visceral adipose tissue; not indicated for general weight loss. |
| KPV (α‑MSH fragment) | Early research only; clinical benefit not established. | On‑demand melanocortin agonist; nausea and BP elevations can occur; dose limits apply. |
| Semax / Selank | Not FDA‑approved; studied mainly outside the U.S. | Not FDA‑approved; studied mainly outside the U.S. |
| MOTS‑c | Experimental; human outcomes pending. | Experimental; human outcomes pending. |
Swipe left or scroll horizontally to view the full table.
Regulatory reminder: Most investigational peptides are not eligible for U.S. compounding from bulk under 503A/503B. For athletes, some may violate anti‑doping rules—always disclose use to your care team.
Safety: Why Physician Supervision Matters
Decades of Experience with Elite & Everyday Athletes
For more than three decades, Dr. Rick Lehman has treated professional and Olympic athletes while helping active adults preserve joint function as they age. Our clinic’s mission is to preserve performance for life using ethical, evidence‑guided strategies that prioritize long‑term orthopedic health.
Considering Peptide Therapy?
Peptides can be valuable tools when used judiciously within a comprehensive plan. To determine whether peptide‑based therapy aligns with your goals, schedule a personalized evaluation at one of our clinics in St Louis, MO or Menlo Park, CA.
Educational content only; not medical advice. Treatments are offered at physician discretion based on safety, legality, and clinical need.
© 2025 Joint & Performance Clinic. All rights reserved.
